Systech 19.03.24

Systech has launched a rework solution for exception management designed to help manufacturers, CMOs (Contract Manufacturing Organization), CPOs (Contract Packaging Organisations) and distributors minimize data misalignment, product delays and associated risks in the pharmaceutical sector.

Exception management focuses on identifying and resolving issues that arise during pharmaceutical product manufacturing and distribution, used in the pharmaceutical sector for patient safety, regulatory compliance concerns, and to avoid supply chain delays and product quarantine. 

Systech says that as trading partners implement and fine-tune their processes to adhere to the Drug Quality and Security Act (DSCSA) guidelines and systems, the volume of errors related to discrepancies between the data received and the product received in the shipment is expected to grow 5 to 10 times.  

Apparently, Systech’s solution also offers rework starting on the line and through the supply chain, with rapid deployment, connectivity to any Level 4 platform and a built-in data inspector with the flexibility to adapt to any workflow and ecosystem. 

The company says the solution provides a quick path to compliance with Electronic Product Code Information Services (EPCIS) checker serving as a built-in data inspector, reducing the hours needed to check and reconcile the data; a communication hub that automates notifications to trading partners and regulatory authorities, avoiding product quarantine and supply chain delays; and multi -scan and mobile flexibility to optimize production and resolution time. 

“Our new feature-rich, exception handling solution addresses a diverse set of use cases, leveraging our vast experience in providing rework up and down the stack and ensuring seamless trading partner connectivity,” said Sreedhar Patnala, vice president of digital products at Systech. 

“The pharmaceutical industry must prioritize efficient exception handling and rework solutions to maintain product quality, patient safety and supply chain integrity,” said Rick Seibert, senior vice president of Sharp Packaging. “As a full stack L1-L5 provider, Systech leverages its solution to streamline data from all sites and handles rework using a simple, cloud-based tool with no adverse impact on production.” 

In similar news, Sanofi Consumer Healthcare joined PA Consulting and PulPac’s Blister Pack Collective in a bid to produce fibre-based blister packs that can be recycled in the paper waste stream and phase out ‘problem plastics’ in pharmaceutical packaging. Formed in 2022, the Blister Pack Collective consists of businesses in the pharma, consumer health, and FMCG industries and intends to create a tablet blister pack made of PulPac’s Dry Molded Fiber; it is expected to cut down on the 100,000 tonnes of plastic said to be used in the medical packaging sector every year. 

In the same month, Faller Packaging developed a recyclable, fibre-based, semi-transparent and tamper-proof label with first-opening indication, designed for use in the pharmaceutical industry. In a bid to ensure recyclability, the company states the semi-transparent label is made of a fibre-based, unmixed material, using paper sourced from sustainable forestry.

If you liked this story, you might also enjoy: 

The Brief: How viable is biorecycling for plastics? 

Report: How the top brands are progressing on packaging sustainability 

The Brief: Using ocean-bound plastic in packaging – how, why and should we? 

Sustainable Packaging Summit: Is the world on track to tackle plastic pollution? Reflecting on five years of the Global Commitment